Equillium, Inc. - EQ
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 13, 2026 | SCHEDULE 13G | Affinity Asset Advisors, LLC | 6.5% | 4,100,000 | View |
| Aug 13, 2026 | SCHEDULE 13G | Michael Cho | 6.5% | 4,100,000 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 7.25% | 4,832,767 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 7.25% | 4,832,767 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 7.25% | 4,832,767 | View |
| May 15, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management, LLC | 9.9% | 6,603,754 | View |
| May 15, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management GP, LLC | 9.5% | 6,306,184 | View |
| May 15, 2026 | SCHEDULE 13G/A | Daniel Schneeberger | 9.9% | 6,603,754 | View |
| May 15, 2026 | SCHEDULE 13G/A | Decheng Capital Management IV (Cayman), LLC | 6.7% | 4,271,423 | View |
| May 15, 2026 | SCHEDULE 13G/A | Decheng Capital Global Life Sciences Fund IV, L.P. | 6.7% | 4,271,423 | View |
| May 15, 2026 | SCHEDULE 13G/A | Decheng Capital Global Healthcare Fund (Master), LP | 2.3% | 1,461,598 | View |
| May 15, 2026 | SCHEDULE 13G/A | Decheng Capital Global Healthcare GP, LLC | 2.3% | 1,461,598 | View |
| May 15, 2026 | SCHEDULE 13G/A | Xiangmin Cui | 8.9% | 5,733,021 | View |
| May 07, 2026 | SCHEDULE 13G | Aberdeen Group plc | 5.3% | 3,352,837 | View |
| May 07, 2026 | SCHEDULE 13G | abrdn Inc. | 5.3% | 3,352,837 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.